Phase I/II, open-label, dose-escalating study of MDX-060 administered weekly for 4 weeks in subjects with refractory/relapsed CD30 positive lymphoma Meeting Abstract
| Authors: | Ansell, S. M.; Byrd, J. C.; Horwitz, S. M.; Borchmann, P.; Engert, A.; Strair, R.; Khan, K. D.; Fischkoff, S. A.; Yellin, M. |
| Abstract Title: | Phase I/II, open-label, dose-escalating study of MDX-060 administered weekly for 4 weeks in subjects with refractory/relapsed CD30 positive lymphoma |
| Meeting Title: | 46th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 104 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2004 Dec 4-7 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2004-11-16 |
| Start Page: | 721A |
| Language: | English |
| ACCESSION: | WOS:000225127502637 |
| PROVIDER: | wos |
| PUBMED: | 15562524 |
| DOI: | 10.1182/blood.V104.11.2636.2636 |
| Notes: | Meeting Abstract: 2636 -- 46th Annual Meeting of the American-Society-of-Hematology -- DEC 04-07, 2004 -- San Diego, CA -- 1 -- Source: Wos |
